Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119879) titled 'The Analgesic Efficacy of Tegileridine Following Total Hip Arthroplasty' on March 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The 97th Hospital of the Chinese People's Liberation Army Joint Logistics Support Force
Condition:
Postoperative pain
Intervention:
Tegileridine Group:Tegileridine 0.1 mg/kg diluted to 100 ml with normal saline for postoperative analgesia.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-31
Target Sample Size: Tegileridine Group:65;Sufentanil Group:65;
Countries of Recruitment:
China
To know more, visit https:...